Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- GERN
- Price
- 1.45
- Stock movement down
- -0.04 (-2.68%)
- Company name
- Geron Corporation
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 876.53M
- Ent value
- 926.61M
- Price/Sales
- 29.73
- Price/Book
- 3.00
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 16.08%
- 1 year return
- -58.45%
- 3 year return
- 2.92%
- 5 year return
- -5.85%
- 10 year return
- -10.07%
Last updated: 2025-05-29
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
GERN does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 29.73 |
| Price to Book | 3.00 |
| EV to Sales | 31.43 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 604.50M |
| EPS (TTM) | -0.30 |
| FCF per share (TTM) | -0.33 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 29.48M |
| Gross profit (TTM) | 28.46M |
| Operating income (TTM) | -207.97M |
| Net income (TTM) | -201.19M |
| EPS (TTM) | -0.30 |
| EPS (1y forward) | -0.06 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 96.53% |
| Operating margin (TTM) | -705.46% |
| Profit margin (TTM) | -682.48% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 60.34M |
| Net receivables | 28.01M |
| Total current assets | 398.06M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 4.65M |
| Total assets | 402.71M |
| Accounts payable | 13.73M |
| Short/Current long term debt | 15.70M |
| Total current liabilities | 137.93M |
| Total liabilities | 110.42M |
| Shareholder's equity | 292.28M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -214.97M |
| Capital expenditures (TTM) | 885.00K |
| Free cash flow (TTM) | -215.86M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -68.84% |
| Return on Assets | -49.96% |
| Return on Invested Capital | -65.64% |
| Cash Return on Invested Capital | -70.43% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.49 |
| Daily high | 1.53 |
| Daily low | 1.43 |
| Daily Volume | 8.44M |
| All-time high | 65.99 |
| 1y analyst estimate | 7.61 |
| Beta | 0.52 |
| EPS (TTM) | -0.30 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GERN | S&P500 | |
| Current price drop from All-time high | -97.80% | -4.11% |
| Highest price drop | -98.66% | -56.47% |
| Date of highest drop | 18 Mar 2020 | 9 Mar 2009 |
| Avg drop from high | -85.66% | -11.06% |
| Avg time to new high | 242 days | 12 days |
| Max time to new high | 6345 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
876.53M
Marketcap category
Small-cap
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Employees
141
Website
Investor relations
-
SEC filings
CEO
John A. Scarlett
Country
USA
City
Menlo Park
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page